# European School of Molecular Medicine

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/european-school-of-molecular-medicine/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 85.5 |
| Citations | 67,486 |
| City | Milan |
| Country | IT |
| Description | European School of Molecular Medicine is a research organisation in Milan, IT. OpenAlex records 779 works and 67,486 citations for it. 159 researchers list it as their most recent affiliation. |
| Homepage | http://www.semm.it/ |
| OpenAlex ID | https://openalex.org/I4210109436 |
| Researchers | 159 |
| ROR ID | https://ror.org/0221k0h06 |
| Type | other |
| Works | 779 |

## University papers

- [Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis](https://scholariq.org/papers/effects-of-kras-braf-nras-and-pik3ca-mutations-on-the-efficacy-of-cetuximab-plus/)
- [Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial](https://scholariq.org/papers/dual-targeted-therapy-with-trastuzumab-and-lapatinib-in-treatment-refractory/)
- [Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition](https://scholariq.org/papers/tumor-cells-can-follow-distinct-evolutionary-paths-to-become-resistant-to/)
- [Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma](https://scholariq.org/papers/reversible-and-adaptive-resistance-to-braf-v600e-inhibition-in-melanoma/)
- [Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab](https://scholariq.org/papers/association-of-kras-p-g13d-mutation-with-outcome-in-patients-with-chemotherapy/)
- [Polyclonal Secondary <i>FGFR2</i> Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion–Positive Cholangiocarcinoma](https://scholariq.org/papers/polyclonal-secondary-i-fgfr2-i-mutations-drive-acquired-resistance-to-fgfr/)

## University top topics

Showing 8 of 25.

- [Epigenetics and DNA Methylation](https://scholariq.org/topics/epigenetics-and-dna-methylation/)
- [RNA modifications and cancer](https://scholariq.org/topics/rna-modifications-and-cancer/)
- [MicroRNA in disease regulation](https://scholariq.org/topics/microrna-in-disease-regulation/)
- [Cancer-related molecular mechanisms research](https://scholariq.org/topics/cancer-related-molecular-mechanisms-research/)
- [RNA Research and Splicing](https://scholariq.org/topics/rna-research-and-splicing/)
- [Genomics and Chromatin Dynamics](https://scholariq.org/topics/genomics-and-chromatin-dynamics/)
- [Pluripotent Stem Cells Research](https://scholariq.org/topics/pluripotent-stem-cells-research/)
- [Cancer-related gene regulation](https://scholariq.org/topics/cancer-related-gene-regulation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.